Zogenix, Inc.
Zogenix, Inc. 0M3O.L Peers
See (0M3O.L) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 0M3O.L | £40.75 | +54.53% | 0 | -9.37 | -£4.35 | N/A |
| 0R0H.L | £403.00 | -0.20% | 152.1B | 21.00 | £19.19 | +0.40% |
| 0QZU.L | £444.63 | +0.13% | 114.2B | 46.93 | £9.48 | N/A |
| 0M3Q.L | £166.27 | -0.06% | 74B | 38.14 | £4.36 | +1.12% |
| 0R2M.L | £597.27 | +0.04% | 63.4B | 8.50 | £70.31 | +0.29% |
| 0HD2.L | £290.13 | -0.89% | 37.8B | -38.73 | -£7.49 | N/A |
| 0HAV.L | £111.50 | +0.35% | 31.8B | 26.90 | £4.15 | +0.87% |
| 0RD1.L | £510.46 | -1.12% | 29.9B | -401.94 | -£1.27 | N/A |
| 0JDM.L | £139.38 | -1.12% | 24.1B | 25.17 | £5.54 | N/A |
| 0K10.L | £1,154.78 | +0.66% | 24B | 33.92 | £34.05 | N/A |
Stock Comparison
0M3O.L vs 0R0H.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0R0H.L has a market cap of 152.1B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0R0H.L trades at £403.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0R0H.L's P/E ratio is 21.00. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0R0H.L's ROE of +0.13%. Regarding short-term risk, 0M3O.L is less volatile compared to 0R0H.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0QZU.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0QZU.L has a market cap of 114.2B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0QZU.L trades at £444.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0QZU.L's P/E ratio is 46.93. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0QZU.L's ROE of -0.06%. Regarding short-term risk, 0M3O.L is less volatile compared to 0QZU.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0M3Q.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0M3Q.L has a market cap of 74B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0M3Q.L trades at £166.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0M3Q.L's P/E ratio is 38.14. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0M3Q.L's ROE of +0.51%. Regarding short-term risk, 0M3O.L is less volatile compared to 0M3Q.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0R2M.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0R2M.L has a market cap of 63.4B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0R2M.L trades at £597.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0R2M.L's P/E ratio is 8.50. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0R2M.L's ROE of +0.15%. Regarding short-term risk, 0M3O.L is less volatile compared to 0R2M.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0HD2.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0HD2.L has a market cap of 37.8B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0HD2.L trades at £290.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0HD2.L's P/E ratio is -38.73. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0HD2.L's ROE of +9.05%. Regarding short-term risk, 0M3O.L is less volatile compared to 0HD2.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0HAV.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0HAV.L has a market cap of 31.8B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0HAV.L trades at £111.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0HAV.L's P/E ratio is 26.90. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0HAV.L's ROE of +0.21%. Regarding short-term risk, 0M3O.L is less volatile compared to 0HAV.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0RD1.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0RD1.L has a market cap of 29.9B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0RD1.L trades at £510.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0RD1.L's P/E ratio is -401.94. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0RD1.L's ROE of +0.14%. Regarding short-term risk, 0M3O.L is less volatile compared to 0RD1.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0JDM.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0JDM.L has a market cap of 24.1B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0JDM.L trades at £139.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0JDM.L's P/E ratio is 25.17. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0JDM.L's ROE of +0.21%. Regarding short-term risk, 0M3O.L is less volatile compared to 0JDM.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0K10.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0K10.L has a market cap of 24B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0K10.L trades at £1,154.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0K10.L's P/E ratio is 33.92. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0K10.L's ROE of -5.82%. Regarding short-term risk, 0M3O.L is less volatile compared to 0K10.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0REZ.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0REZ.L has a market cap of 22.6B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0REZ.L trades at £183.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0REZ.L's P/E ratio is 31.26. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0REZ.L's ROE of +0.06%. Regarding short-term risk, 0M3O.L is less volatile compared to 0REZ.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0LTI.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0LTI.L has a market cap of 21.2B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0LTI.L trades at £356.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0LTI.L's P/E ratio is 31.24. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0LTI.L's ROE of +0.39%. Regarding short-term risk, 0M3O.L is more volatile compared to 0LTI.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0R1B.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0R1B.L has a market cap of 18.9B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0R1B.L trades at £128.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0R1B.L's P/E ratio is N/A. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0R1B.L's ROE of +0.09%. Regarding short-term risk, 0M3O.L is less volatile compared to 0R1B.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0SAN.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0SAN.L has a market cap of 17.5B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0SAN.L trades at £40.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0SAN.L's P/E ratio is N/A. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0SAN.L's ROE of +0.01%. Regarding short-term risk, 0M3O.L is less volatile compared to 0SAN.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0RQO.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0RQO.L has a market cap of 16.8B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0RQO.L trades at £254.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0RQO.L's P/E ratio is -199.80. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0RQO.L's ROE of +0.18%. Regarding short-term risk, 0M3O.L is less volatile compared to 0RQO.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0J8Z.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0J8Z.L has a market cap of 13.1B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0J8Z.L trades at £82.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0J8Z.L's P/E ratio is 18.15. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0J8Z.L's ROE of -0.46%. Regarding short-term risk, 0M3O.L is less volatile compared to 0J8Z.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0J9P.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0J9P.L has a market cap of 12.6B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0J9P.L trades at £65.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0J9P.L's P/E ratio is 15.51. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0J9P.L's ROE of +0.01%. Regarding short-term risk, 0M3O.L is less volatile compared to 0J9P.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0JAV.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0JAV.L has a market cap of 12.2B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0JAV.L trades at £67.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0JAV.L's P/E ratio is -17.78. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0JAV.L's ROE of -4.47%. Regarding short-term risk, 0M3O.L is less volatile compared to 0JAV.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0K6R.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0K6R.L has a market cap of 12.2B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0K6R.L trades at £123.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0K6R.L's P/E ratio is 169.26. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0K6R.L's ROE of +0.12%. Regarding short-term risk, 0M3O.L is less volatile compared to 0K6R.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0IJO.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0IJO.L has a market cap of 11.7B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0IJO.L trades at £42.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0IJO.L's P/E ratio is 46.26. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0IJO.L's ROE of +0.29%. Regarding short-term risk, 0M3O.L is less volatile compared to 0IJO.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0HNC.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0HNC.L has a market cap of 11.3B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0HNC.L trades at £59.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0HNC.L's P/E ratio is 275.07. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0HNC.L's ROE of +0.09%. Regarding short-term risk, 0M3O.L is less volatile compared to 0HNC.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0LSZ.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0LSZ.L has a market cap of 9.7B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0LSZ.L trades at £11.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0LSZ.L's P/E ratio is 1.55. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0LSZ.L's ROE of -0.55%. Regarding short-term risk, 0M3O.L is less volatile compared to 0LSZ.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0I3Q.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0I3Q.L has a market cap of 8.3B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0I3Q.L trades at £78.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0I3Q.L's P/E ratio is 85.50. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0I3Q.L's ROE of +0.20%. Regarding short-term risk, 0M3O.L is less volatile compared to 0I3Q.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0J2O.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0J2O.L has a market cap of 6.7B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0J2O.L trades at £54.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0J2O.L's P/E ratio is 18.18. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0J2O.L's ROE of +1.22%. Regarding short-term risk, 0M3O.L is less volatile compared to 0J2O.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0HOJ.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0HOJ.L has a market cap of 6.3B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0HOJ.L trades at £98.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0HOJ.L's P/E ratio is -8.87. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0HOJ.L's ROE of -0.49%. Regarding short-term risk, 0M3O.L is less volatile compared to 0HOJ.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0JDI.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0JDI.L has a market cap of 5.3B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0JDI.L trades at £33.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0JDI.L's P/E ratio is -1184.62. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0JDI.L's ROE of -0.00%. Regarding short-term risk, 0M3O.L is more volatile compared to 0JDI.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0HKF.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0HKF.L has a market cap of 5.1B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0HKF.L trades at £103.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0HKF.L's P/E ratio is -27.94. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0HKF.L's ROE of -3.64%. Regarding short-term risk, 0M3O.L is less volatile compared to 0HKF.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0VGI.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0VGI.L has a market cap of 4.7B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0VGI.L trades at £31.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0VGI.L's P/E ratio is -13.01. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0VGI.L's ROE of +0.19%. Regarding short-term risk, 0M3O.L is less volatile compared to 0VGI.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0QQO.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0QQO.L has a market cap of 4.4B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0QQO.L trades at £97.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0QQO.L's P/E ratio is 4.42. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0QQO.L's ROE of +0.14%. Regarding short-term risk, 0M3O.L is less volatile compared to 0QQO.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0QND.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0QND.L has a market cap of 3.8B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0QND.L trades at £50.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0QND.L's P/E ratio is 31.28. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0QND.L's ROE of +0.09%. Regarding short-term risk, 0M3O.L is less volatile compared to 0QND.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0Y5E.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0Y5E.L has a market cap of 3.7B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0Y5E.L trades at £27.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0Y5E.L's P/E ratio is -33.23. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0Y5E.L's ROE of -0.04%. Regarding short-term risk, 0M3O.L is less volatile compared to 0Y5E.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0L35.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0L35.L has a market cap of 3.6B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0L35.L trades at £37.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0L35.L's P/E ratio is -8.79. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0L35.L's ROE of -0.20%. Regarding short-term risk, 0M3O.L is less volatile compared to 0L35.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0VQA.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0VQA.L has a market cap of 3.1B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0VQA.L trades at £27.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0VQA.L's P/E ratio is -37.22. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0VQA.L's ROE of -0.14%. Regarding short-term risk, 0M3O.L is less volatile compared to 0VQA.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0ILL.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0ILL.L has a market cap of 2.7B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0ILL.L trades at £52.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0ILL.L's P/E ratio is 15.84. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0ILL.L's ROE of +0.26%. Regarding short-term risk, 0M3O.L is less volatile compared to 0ILL.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0GZB.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0GZB.L has a market cap of 2.3B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0GZB.L trades at £203.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0GZB.L's P/E ratio is 31.04. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0GZB.L's ROE of +0.01%. Regarding short-term risk, 0M3O.L is more volatile compared to 0GZB.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0I5P.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0I5P.L has a market cap of 2.2B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0I5P.L trades at £32.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0I5P.L's P/E ratio is -24.55. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0I5P.L's ROE of -0.32%. Regarding short-term risk, 0M3O.L is more volatile compared to 0I5P.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0QLN.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0QLN.L has a market cap of 2.1B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0QLN.L trades at £168.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0QLN.L's P/E ratio is 17.10. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0QLN.L's ROE of +0.05%. Regarding short-term risk, 0M3O.L is less volatile compared to 0QLN.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0HF9.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0HF9.L has a market cap of 1.9B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0HF9.L trades at £6.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0HF9.L's P/E ratio is -6.49. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0HF9.L's ROE of -0.17%. Regarding short-term risk, 0M3O.L is less volatile compared to 0HF9.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0LB2.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0LB2.L has a market cap of 1.8B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0LB2.L trades at £32.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0LB2.L's P/E ratio is 24.70. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0LB2.L's ROE of +0.06%. Regarding short-term risk, 0M3O.L is more volatile compared to 0LB2.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0HB0.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0HB0.L has a market cap of 1.8B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0HB0.L trades at £30.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0HB0.L's P/E ratio is -4.75. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0HB0.L's ROE of +0.59%. Regarding short-term risk, 0M3O.L is more volatile compared to 0HB0.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0IMT.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0IMT.L has a market cap of 1.3B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0IMT.L trades at £50.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0IMT.L's P/E ratio is -19.80. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0IMT.L's ROE of +0.00%. Regarding short-term risk, 0M3O.L is more volatile compared to 0IMT.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0IDA.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0IDA.L has a market cap of 1.1B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0IDA.L trades at £9.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0IDA.L's P/E ratio is 12.66. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0IDA.L's ROE of -0.10%. Regarding short-term risk, 0M3O.L is less volatile compared to 0IDA.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0KCS.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0KCS.L has a market cap of 1B. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0KCS.L trades at £1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0KCS.L's P/E ratio is -7.37. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0KCS.L's ROE of -0.03%. Regarding short-term risk, 0M3O.L is less volatile compared to 0KCS.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0JBU.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0JBU.L has a market cap of 974.7M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0JBU.L trades at £9.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0JBU.L's P/E ratio is -1.86. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0JBU.L's ROE of -0.59%. Regarding short-term risk, 0M3O.L is less volatile compared to 0JBU.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0IV3.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0IV3.L has a market cap of 942.6M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0IV3.L trades at £1.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0IV3.L's P/E ratio is -4.12. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0IV3.L's ROE of -0.48%. Regarding short-term risk, 0M3O.L is less volatile compared to 0IV3.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0RGI.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0RGI.L has a market cap of 926.2M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0RGI.L trades at £55.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0RGI.L's P/E ratio is 42.45. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0RGI.L's ROE of +0.14%. Regarding short-term risk, 0M3O.L is more volatile compared to 0RGI.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0O1O.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0O1O.L has a market cap of 867.3M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0O1O.L trades at £73.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0O1O.L's P/E ratio is 13.83. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0O1O.L's ROE of +0.10%. Regarding short-term risk, 0M3O.L is less volatile compared to 0O1O.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0EE0.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0EE0.L has a market cap of 824.8M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0EE0.L trades at £15.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0EE0.L's P/E ratio is 2.19. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0EE0.L's ROE of -4.84%. Regarding short-term risk, 0M3O.L is less volatile compared to 0EE0.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0HFR.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0HFR.L has a market cap of 645.6M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0HFR.L trades at £7.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0HFR.L's P/E ratio is -13.06. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0HFR.L's ROE of -0.31%. Regarding short-term risk, 0M3O.L is less volatile compared to 0HFR.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0K16.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0K16.L has a market cap of 625.4M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0K16.L trades at £14.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0K16.L's P/E ratio is -11.22. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0K16.L's ROE of -9.32%. Regarding short-term risk, 0M3O.L is less volatile compared to 0K16.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0JDK.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0JDK.L has a market cap of 601.1M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0JDK.L trades at £1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0JDK.L's P/E ratio is -0.78. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0JDK.L's ROE of -0.51%. Regarding short-term risk, 0M3O.L is less volatile compared to 0JDK.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0QNA.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0QNA.L has a market cap of 549M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0QNA.L trades at £44.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0QNA.L's P/E ratio is -76.50. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0QNA.L's ROE of +1.59%. Regarding short-term risk, 0M3O.L is less volatile compared to 0QNA.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0OB3.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0OB3.L has a market cap of 482M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0OB3.L trades at £2.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0OB3.L's P/E ratio is -4.01. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0OB3.L's ROE of -0.43%. Regarding short-term risk, 0M3O.L is less volatile compared to 0OB3.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0LOV.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0LOV.L has a market cap of 463.8M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0LOV.L trades at £7.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0LOV.L's P/E ratio is -18.85. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0LOV.L's ROE of +58.06%. Regarding short-term risk, 0M3O.L is less volatile compared to 0LOV.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0DTF.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0DTF.L has a market cap of 416.7M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0DTF.L trades at £24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0DTF.L's P/E ratio is 14.72. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0DTF.L's ROE of +0.03%. Regarding short-term risk, 0M3O.L is more volatile compared to 0DTF.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0W4N.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0W4N.L has a market cap of 402.7M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0W4N.L trades at £22.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0W4N.L's P/E ratio is -18.72. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0W4N.L's ROE of -0.24%. Regarding short-term risk, 0M3O.L is less volatile compared to 0W4N.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0K3W.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0K3W.L has a market cap of 396.5M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0K3W.L trades at £4.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0K3W.L's P/E ratio is -39.47. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0K3W.L's ROE of -0.15%. Regarding short-term risk, 0M3O.L is less volatile compared to 0K3W.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0RNK.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0RNK.L has a market cap of 396.1M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0RNK.L trades at £2.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0RNK.L's P/E ratio is -2.23. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0RNK.L's ROE of +1.98%. Regarding short-term risk, 0M3O.L is less volatile compared to 0RNK.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0RA9.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0RA9.L has a market cap of 350.2M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0RA9.L trades at £5.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0RA9.L's P/E ratio is -2.23. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0RA9.L's ROE of -2.11%. Regarding short-term risk, 0M3O.L is less volatile compared to 0RA9.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0IGA.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0IGA.L has a market cap of 347.9M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0IGA.L trades at £6.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0IGA.L's P/E ratio is 2.16. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0IGA.L's ROE of -0.27%. Regarding short-term risk, 0M3O.L is less volatile compared to 0IGA.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0H7R.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0H7R.L has a market cap of 321.3M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0H7R.L trades at £5.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0H7R.L's P/E ratio is -7.41. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0H7R.L's ROE of -1.65%. Regarding short-term risk, 0M3O.L is less volatile compared to 0H7R.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0J4V.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0J4V.L has a market cap of 285.1M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0J4V.L trades at £1.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0J4V.L's P/E ratio is -0.82. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0J4V.L's ROE of +0.37%. Regarding short-term risk, 0M3O.L is less volatile compared to 0J4V.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0GP7.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0GP7.L has a market cap of 217.7M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0GP7.L trades at £2.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0GP7.L's P/E ratio is -1.27. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0GP7.L's ROE of -0.38%. Regarding short-term risk, 0M3O.L is more volatile compared to 0GP7.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0RDB.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0RDB.L has a market cap of 210.1M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0RDB.L trades at £2.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0RDB.L's P/E ratio is -30.80. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0RDB.L's ROE of -0.03%. Regarding short-term risk, 0M3O.L is less volatile compared to 0RDB.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0NZY.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0NZY.L has a market cap of 201.2M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0NZY.L trades at £39.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0NZY.L's P/E ratio is 30.50. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0NZY.L's ROE of +0.14%. Regarding short-term risk, 0M3O.L is more volatile compared to 0NZY.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0QAV.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0QAV.L has a market cap of 169.8M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0QAV.L trades at £3.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0QAV.L's P/E ratio is -2.66. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0QAV.L's ROE of +2.83%. Regarding short-term risk, 0M3O.L is less volatile compared to 0QAV.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0H8T.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0H8T.L has a market cap of 164M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0H8T.L trades at £1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0H8T.L's P/E ratio is -1.11. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0H8T.L's ROE of -0.94%. Regarding short-term risk, 0M3O.L is less volatile compared to 0H8T.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0IIM.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0IIM.L has a market cap of 161.6M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0IIM.L trades at £0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0IIM.L's P/E ratio is -0.13. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0IIM.L's ROE of +0.40%. Regarding short-term risk, 0M3O.L is less volatile compared to 0IIM.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0IFK.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0IFK.L has a market cap of 155.7M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0IFK.L trades at £1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0IFK.L's P/E ratio is -0.68. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0IFK.L's ROE of -1.66%. Regarding short-term risk, 0M3O.L is less volatile compared to 0IFK.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0QOI.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0QOI.L has a market cap of 154.2M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0QOI.L trades at £7.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0QOI.L's P/E ratio is -9.09. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0QOI.L's ROE of +1.28%. Regarding short-term risk, 0M3O.L is less volatile compared to 0QOI.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0N4A.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0N4A.L has a market cap of 142M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0N4A.L trades at £0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0N4A.L's P/E ratio is -1.02. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0N4A.L's ROE of -0.23%. Regarding short-term risk, 0M3O.L is more volatile compared to 0N4A.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0QXX.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0QXX.L has a market cap of 136.3M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0QXX.L trades at £3.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0QXX.L's P/E ratio is 1.02. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0QXX.L's ROE of -0.36%. Regarding short-term risk, 0M3O.L is less volatile compared to 0QXX.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0UNL.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0UNL.L has a market cap of 127.5M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0UNL.L trades at £0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0UNL.L's P/E ratio is -0.31. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0UNL.L's ROE of -2.62%. Regarding short-term risk, 0M3O.L is less volatile compared to 0UNL.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0QN1.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0QN1.L has a market cap of 120.2M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0QN1.L trades at £12.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0QN1.L's P/E ratio is -7.72. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0QN1.L's ROE of -1.11%. Regarding short-term risk, 0M3O.L is less volatile compared to 0QN1.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0R1D.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0R1D.L has a market cap of 111M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0R1D.L trades at £0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0R1D.L's P/E ratio is -0.37. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0R1D.L's ROE of -3.51%. Regarding short-term risk, 0M3O.L is less volatile compared to 0R1D.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0KCC.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0KCC.L has a market cap of 96.4M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0KCC.L trades at £2.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0KCC.L's P/E ratio is -3.80. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0KCC.L's ROE of -7.67%. Regarding short-term risk, 0M3O.L is more volatile compared to 0KCC.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0OCQ.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0OCQ.L has a market cap of 90.8M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0OCQ.L trades at £0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0OCQ.L's P/E ratio is -3.03. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0OCQ.L's ROE of -4.66%. Regarding short-term risk, 0M3O.L is more volatile compared to 0OCQ.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0SZI.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0SZI.L has a market cap of 89.4M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0SZI.L trades at £7.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0SZI.L's P/E ratio is -23.43. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0SZI.L's ROE of -0.37%. Regarding short-term risk, 0M3O.L is less volatile compared to 0SZI.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0O8G.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0O8G.L has a market cap of 88.9M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0O8G.L trades at £3.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0O8G.L's P/E ratio is -14.05. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0O8G.L's ROE of -6.17%. Regarding short-term risk, 0M3O.L is more volatile compared to 0O8G.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0RU5.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0RU5.L has a market cap of 75M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0RU5.L trades at £1.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0RU5.L's P/E ratio is -0.55. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0RU5.L's ROE of -1.02%. Regarding short-term risk, 0M3O.L is more volatile compared to 0RU5.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0Q77.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0Q77.L has a market cap of 73.6M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0Q77.L trades at £1.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0Q77.L's P/E ratio is -4.08. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0Q77.L's ROE of +0.26%. Regarding short-term risk, 0M3O.L is more volatile compared to 0Q77.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0HX7.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0HX7.L has a market cap of 57.2M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0HX7.L trades at £0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0HX7.L's P/E ratio is -0.66. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0HX7.L's ROE of -0.53%. Regarding short-term risk, 0M3O.L is less volatile compared to 0HX7.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0DOL.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0DOL.L has a market cap of 52.2M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0DOL.L trades at £1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0DOL.L's P/E ratio is 4.37. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0DOL.L's ROE of +0.03%. Regarding short-term risk, 0M3O.L is more volatile compared to 0DOL.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0M40.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0M40.L has a market cap of 49M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0M40.L trades at £1.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0M40.L's P/E ratio is -1.36. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0M40.L's ROE of -0.59%. Regarding short-term risk, Volatility data is not available for a full comparison. 0M3O.L has daily volatility of 0.39 and 0M40.L has daily volatility of N/A.
0M3O.L vs 0HOH.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0HOH.L has a market cap of 48.7M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0HOH.L trades at £8.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0HOH.L's P/E ratio is -0.77. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0HOH.L's ROE of +18.95%. Regarding short-term risk, 0M3O.L is less volatile compared to 0HOH.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0JGL.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0JGL.L has a market cap of 47.9M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0JGL.L trades at £1.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0JGL.L's P/E ratio is -0.55. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0JGL.L's ROE of -0.59%. Regarding short-term risk, 0M3O.L is less volatile compared to 0JGL.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0HIY.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0HIY.L has a market cap of 47.6M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0HIY.L trades at £7.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0HIY.L's P/E ratio is -2.02. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0HIY.L's ROE of +0.18%. Regarding short-term risk, 0M3O.L is less volatile compared to 0HIY.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0R3M.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0R3M.L has a market cap of 45.1M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0R3M.L trades at £1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0R3M.L's P/E ratio is -2.73. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0R3M.L's ROE of -1.88%. Regarding short-term risk, 0M3O.L is more volatile compared to 0R3M.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0IL8.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0IL8.L has a market cap of 33.5M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0IL8.L trades at £0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0IL8.L's P/E ratio is -0.11. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0IL8.L's ROE of +0.05%. Regarding short-term risk, 0M3O.L is less volatile compared to 0IL8.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0QKQ.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0QKQ.L has a market cap of 33.4M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0QKQ.L trades at £2.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0QKQ.L's P/E ratio is -266.00. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0QKQ.L's ROE of -0.40%. Regarding short-term risk, 0M3O.L is less volatile compared to 0QKQ.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0QFK.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0QFK.L has a market cap of 26.5M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0QFK.L trades at £0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0QFK.L's P/E ratio is -0.55. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0QFK.L's ROE of +0.91%. Regarding short-term risk, 0M3O.L is more volatile compared to 0QFK.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0JQ2.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0JQ2.L has a market cap of 26.5M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0JQ2.L trades at £4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0JQ2.L's P/E ratio is N/A. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0JQ2.L's ROE of -3.69%. Regarding short-term risk, 0M3O.L is more volatile compared to 0JQ2.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0T6G.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0T6G.L has a market cap of 23.4M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0T6G.L trades at £1.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0T6G.L's P/E ratio is -40.00. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0T6G.L's ROE of -1.80%. Regarding short-term risk, 0M3O.L is less volatile compared to 0T6G.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0JW9.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0JW9.L has a market cap of 14M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0JW9.L trades at £2.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0JW9.L's P/E ratio is -4.06. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0JW9.L's ROE of -1.27%. Regarding short-term risk, 0M3O.L is more volatile compared to 0JW9.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0YC0.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0YC0.L has a market cap of 12M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0YC0.L trades at £0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0YC0.L's P/E ratio is -0.64. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0YC0.L's ROE of -2.74%. Regarding short-term risk, 0M3O.L is less volatile compared to 0YC0.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0KF3.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0KF3.L has a market cap of 5.1M. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0KF3.L trades at £0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0KF3.L's P/E ratio is -0.63. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0KF3.L's ROE of +4.54%. Regarding short-term risk, 0M3O.L is less volatile compared to 0KF3.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs CBX.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, CBX.L has a market cap of 2.2M. Regarding current trading prices, 0M3O.L is priced at £40.75, while CBX.L trades at £0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas CBX.L's P/E ratio is -0.37. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to CBX.L's ROE of -1.00%. Regarding short-term risk, 0M3O.L is less volatile compared to CBX.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs KNB.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, KNB.L has a market cap of 1.4M. Regarding current trading prices, 0M3O.L is priced at £40.75, while KNB.L trades at £0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas KNB.L's P/E ratio is -0.23. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to KNB.L's ROE of -1.22%. Regarding short-term risk, 0M3O.L is more volatile compared to KNB.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0L85.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0L85.L has a market cap of 606.4K. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0L85.L trades at £0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0L85.L's P/E ratio is -0.00. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0L85.L's ROE of -19.05%. Regarding short-term risk, 0M3O.L is more volatile compared to 0L85.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0M3O.L.
0M3O.L vs 0G99.L Comparison
0M3O.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0M3O.L stands at 0. In comparison, 0G99.L has a market cap of 338.6K. Regarding current trading prices, 0M3O.L is priced at £40.75, while 0G99.L trades at £0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0M3O.L currently has a P/E ratio of -9.37, whereas 0G99.L's P/E ratio is -0.36. In terms of profitability, 0M3O.L's ROE is -0.83%, compared to 0G99.L's ROE of -0.01%. Regarding short-term risk, 0M3O.L is more volatile compared to 0G99.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0M3O.L.